CapsoVision
CV
NASDAQ
IPO2025
about CV
CapsoVision is a medical technology company that develops and sells advanced, wire-free capsule endoscopy systems, like its flagship CapsoCam Plus, which patients swallow to non-invasively capture 360° panoramic video of the gastrointestinal tract for diagnostic and screening purposes, with images reviewed via its cloud-based software.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $10.78 | $15.37 | $9.93 | $552.75M | 2.77M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$0.17 | 29.73 | 174.78 | -226.65% | -223.88% | 6.88% |